All Stories

  1. Melatonin in preservation solutions prevents ischemic injury in rat kidneys
  2. Truncation limits of patient-based real-time quality control: a new model derived from between-subject biological variations
  3. Systematic review and meta-analysis of within-subject and between-subject biological variation estimates of 20 haematological parameters
  4. The short story of the long-term Sigma metric: shift cannot be treated as a linear parameter
  5. Quality will determine the future of mass spectrometry imaging in clinical laboratories: the need for standardization
  6. Measurement uncertainty in laboratory medicine: the bridge between medical and industrial metrology
  7. Proteomic Analysis of Liver Preservation Solutions Prior to Liver Transplantation
  8. Within-subject and between-subject biological variation estimates of 21 hematological parameters in 30 healthy subjects
  9. A Critical Appraisal Checklist (BIVAC), to evaluate paper on Biological Variation
  10. Biological Variation Estimates Obtained from 91 Healthy Study Participants for 9 Enzymes in Serum
  11. Evaluation of the performance of INDEXOR® in the archive unit of a clinical laboratory: a step to Lean laboratory
  12. Perchlorate Exposure Through Water and Milk in Istanbul
  13. Z transformation is the gold standard for computing the sigma metric
  14. How can we evaluate differences between serial measurements on the same sample? A new approach based on within-subject biological variation
  15. Sigma metric or defects per million opportunities (DPMO): the performance of clinical laboratories should be evaluated by the Sigma metrics at decimal level with DPMOs
  16. sigma metric
  17. Hepatitis C virus positive patient diagnosed after detection of atypical cryoglobulin
  18. A rare association: celiac disease and multiple myeloma in an asymptomatic young patient / Asemptomatik genç bir hastada çölyak hastalığı ve multipl myelom’un nadir birlikteliği
  19. Sample collections from healthy volunteers for biological variation estimates’ update: a new project undertaken by the Working Group on Biological Variation established by the European Federation of Clinical Chemistry and Laboratory Medicine
  20. A new approach to calculating the Sigma Metric in clinical laboratories
  21. A checklist for critical appraisal of studies of biological variation
  22. Post‐translational modifications of transthyretin affect the triiodonine‐binding potential
  23. Iodine Status in Turkish Populations and Exposure to Iodide Uptake Inhibitors
  24. Association Between Serum Pregnancy-Associated Plasma Protein-A and Bicarbonate in Hemodialysis Patients
  25. Biological variations of ADAMTS13 and von Willebrand factor in human adults
  26. Reference interval of pregnancy-associated plasma protein-A in healthy men and non-pregnant women
  27. A comparison between turbidimetric inhibition immunoassay and capillary electrophoresis in glycated hemoglobin (HbA1c) measurement
  28. Inhibition of Cholesterol Biosynthesis in Hypercholesterolemia – Is It the Right Choice? / Inhibicija Biosinteze Holesterola u Hiperholesterolemiji – Da Li Je Pravi Izbor?
  29. The comparison of parametric and nonparametric bootstrap methods for reference interval computation in small sample size groups
  30. Evaluating ESWL-induced renal injury based on urinary TNF-α, IL-1α, and IL-6 levels
  31. Challenges in vitamin D analysis / Izazovi u analizi vitamina D
  32. How ISO-15189 laboratory accreditation assures patient safety? / Kako ISO-15189 akreditacija laboratorija osigurava bezbednost pacijenta?
  33. Biological variation in pregnancy-associated plasma protein-A in healthy men and non-pregnant healthy women
  34. Toward standardization of quality assessment in laboratory medicine by using the same matrix samples for both internal and external quality assessments
  35. Six Sigma as a Quality Management Tool: Evaluation of Performance in Laboratory Medicine
  36. Indirect Reference Intervals Estimated from Hospitalized Population for Thyrotropin and Free Thyroxine
  37. Towards standardization of external quality assessment schemes by using bias values based on biological variation
  38. Relationship Between Pregnancy-Associated Plasma Protein-A and Lung Cancer
  39. Response to the Letter to the Editor “A control chart based simply on biological variation is not enough”
  40. Does pregnancy-associated plasma protein A have a role in allergic rhinitis?
  41. A new internal quality control chart based on biological variation
  42. The effect of different preparations of hormone therapy on tumor necrosis factor-α levels in women with surgical menopause
  43. Prolonged elevation of magnesium in the cerebrospinal fluid of patients with severe head injury
  44. High-sensitivity C-reactive protein levels in cerebrospinal fluid and serum in severe head injury: Relationship to tumor necrosis factor-α and interleukin-6
  45. Does l-carnitine have any effect on cold preservation injury of non-fatty liver in the University of Wisconsin solution?
  46. Is there a relationship between cord blood pregnancy-associated plasma protein-A and birth weight and length?
  47. Pregnancy-associated plasma protein-A and asthma
  48. Six Sigma and laboratory consultation
  49. Pregnancy-associated plasma protein A in dialysis patients
  50. High Serum Homocysteine Levels Correlate with a Decrease in the Blood Flow Velocity of the Ophthalmic Artery in Highway Toll Collectors
  51. Westgard multirule for calculated laboratory tests
  52. Modified Levey-Jennings charts for calculated laboratory tests
  53. The reliability of calculated laboratory results